Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – C-o-group doai
Reexamination Certificate
2001-03-08
2002-05-21
Fay, Zohreh (Department: 1614)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
C-o-group doai
C549S416000, C549S356000, C558S083000, C558S073000
Reexamination Certificate
active
06391926
ABSTRACT:
The present invention relates to an optically active binaphthol derivative and an optically active phosphate derivative, as well as their uses. The optically active binaphthol derivative and the optically active phosphate derivative of the present invention are expected to be useful, for example, as intermediates for the preparation of catalysts for various asymmetric syntheses, and the optically active phosphate derivative of the present invention is, by itself, a useful compound having a high asymmetry-identifying ability.
The optically active binaphthol derivative of the present invention and the optically active phosphate derivative derived therefrom, have not heretofore been known, and they are novel compounds.
As an asymmetry-identifying agent, a complex having europium as the center metal, such as Eu-DPM, Eu-PTA, Eu(hfc) or Eu(Tfc), or (R)-(+)-2-methoxy-2-(trifluoromethyl) phenyl acetic acid, is, for example, commercially available.
Further, it is known that 1,1′-binaphthyl-2,2′-diol which is useful as a catalyst element for asymmetric syntheses is useful also as an optical resolution agent (Toda, F., et, al., Chem. Lett., 131(1988), etc.). Further, as an asymmetry-identifying element, 3,3′-(3,5-diphenylphenyl)-1,1′-binaphthyl-2,2′-diyl phosphoric acid is known (76th annual spring meeting of Chemical Society of Japan, 1999, 3C1 05).
The conventional agents employing metal complexes of e.g. europium, which are commercially available, may react depending upon the compounds subjected to asymmetry-identification, and their application range is limited. Further, (R)-(+)-2-methoxy-2-(trifluoromethyl) phenyl acetic acid or the like has hydrogen bonded to sp3 carbon in the nuclear magnetic resonance spectrum analysis (hereinafter referred to simply as NMR), whereby depending upon the type of the compound subjected to asymmetry-identification, the chemical shift is likely to be overlapped so that the determination can not be made.
On the other hand, 1,1′-binaphthyl-2,2′-diol is an excellent agent having a relatively low reactivity with a compound subjected to asymmetry-identification, but its interaction with the compound subjected to asymmetry-identification is low, whereby it is required to be used in a large amount, and its asymmetry-identifying ability is not fully satisfactory.
Further, 3,3,′-(3,5-diphenylphenyl)-1,1′-binaphthyl-2,2′-diyl phosphoric acid shows good performance as an asymmetry-identifying agent, but its ability is incomplete, and it has been desired to develop an agent having a still higher performance.
In order to solve the above problems, the present inventors have conducted an extensive study with an aim to develop a compound having a higher asymmetry-identifying ability and as a result, have found a novel binaphthol derivative as an intermediate and a novel optically active phosphate derivative as an asymmetry-identifying agent. The present invention has been accomplished on the basis of this discovery.
Namely, the present invention provides:
an optically active binaphthol derivative of the following formula (1) or (2):
a process for producing the optically active binaphthol derivative, which comprises reacting 9-anthryl boric acid with (R) or (S)-3,3′-diiodo-1,1′-binaphthyl-2,2′-diyl bis(methoxy methyl ether), followed by hydrolysis;
an optically active phosphate derivative of the following formula (3) or (4):
a process for producing the phosphate derivative, which comprises reacting an optically active binaphthol derivative of the above formula (1) or (2) with phosphorus oxychloride, followed by hydrolysis; and
an asymmetry-identifying agent comprising a phosphate derivative of the above formula (3) or (4).
Now, the present invention will be described in detail with reference to the preferred embodiments.
The binaphthol derivative of the above formula (1) or (2) of the present invention can be prepared by reacting 9-anthryl boric acid obtainable by a method known in literature, with 3,3′-diiodo-1,1′-binaphthyl-2,2′-diyl bis(methoxymethyl)ether obtainable likewise by a method known in literature using commercially available optically active (R) or (S) 1,1′-binaphthyl-2,2′-diol as the starting material, followed by hydrolysis to remove any protecting group. The obtained binaphthol derivative of the above formula (1) or (2) can be converted to the optically active phosphate derivative of the above formula (3) or (4) by reacting it with phosphorus oxychloride, followed by hydrolysis.
The conditions for producing the compound of the above formula (1) or (2) of the present invention are not particularly limited. For example, in a 1,2-dimethoxyethane solvent, in the presence of tetrakis(triphenylphosphine) palladium(O) as a catalyst and barium hydroxide as a base, (R) or (S) 3,3′-diiodo-1,1′-binaphthyl-2,2′-diyl bis(methoxymethyl)ether and 9-anthryl boric acid may be reacted for about 24 hours under a heating condition to obtain 3,3′-bis(9-anthryl)-1,1′-binaphthyl-2,2′-diyl bis(methoxymethyl)ether, which is then reacted for about one day under a heated condition in a toluene/methanol/hydrochloric acid aqueous solution, to obtain the desired product.
The conditions for producing the phosphate derivative of the above formula (3) or (4) of the present invention are not particularly limited. For example, the binaphthol derivative of the above formula (1) or (2) and phosphorus oxychloride may be reacted in a dichloromethane solvent in the presence of triethylamine at room temperature for about 12 hours, and then reacted for about 12 hours in the presence of sodium carbonate in a tetrahydrofuran (hereinafter referred to as THF)/water solvent under a heated condition, and further heated for about 12 hours in an aqueous hydrochloric acid solution, to obtain the desired product.
In the processes of the present invention, there is no particular restriction as to the proportions of the reagents, the amount of the solvent, the temperature, the time, etc.
With respect to their applications, the compounds of the above formulae (1) to (4) of the present invention can be used as asymmetric elements for catalysts for asymmetric syntheses, optical resolution agents, packing materials for optically active columns and asymmetry-identifying agents in NMR measurements.
Now, an application as an asymmetry-identifying agent in NMR measurement will be described.
The optically active phosphate derivative of the present invention has no sp3 carbon, whereby its chemical shift will not overlap with a compound subjected to asymmetry-identification in the NMR measurement.
As a specific method of use of the phosphate derivative of the present invention as an asymmetry-identifying agent in NMR measurement, predetermined amounts of the phosphate derivative of the present invention and the compound to be subjected to asymmetry-identification, are mixed and dissolved in a solvent for NMR measurement, such as heavy chloroform or heavy benzene, whereupon the chemical shift is measured by proton NMR or carbon NMR.
Compounds to which the phosphate derivative of the present invention is applicable as an asymmetry-identifying agent, are not particularly limited. However, the phosphate derivative of the present invention shows an asymmetry-identifying ability against alcohols, amines, carboxylic acids and sulfoxides, which have asymmetry.
The amount of the phosphate derivative of the present invention to be used as an asymmetry-identifying agent should theoretically adequately be an equimolar amount to an optical isomer to form coordination, and a high identification ability can in fact be thereby obtainable. However, there may be a case where the identification ability will be further increased by using it in an amount of about 2 mols, as the case requires. Specifically, in a case where asymmetry-identification of a racemic alcohol is carried out, an adequate asymmetry-identifying ability will be obtained by an addition of only 0.5 mol of the pho
Fay Zohreh
Kwon Brian-Yong S.
Nixon & Vanderhye
Tosoh Corporation
LandOfFree
Optically active phosphate derivative does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Optically active phosphate derivative, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Optically active phosphate derivative will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2840084